BCR and chronic myelogenous leukemia, BCR-ABL1 positive: A fusion gene BCR-ABL, which is frequently found in patients with chronic myeloid leukemia (CML), is responsible for enhanced resistance to apoptosis and increased proliferation of myeloid cells, as well as their adhesion properties [27,28,29,30,31].